Researchers have identified six promising biomarkers that can detect drug-induced kidney injury earlier than traditional markers, enabling more timely monitoring during drug development. These biomarkers could lead to the development of safer medications and improve patient outcomes.
The C-Path-led initiative brought together clinical trial sponsors, eCOA technology providers, and regulators to identify and address eCOA implementation issues. Key resources developed during the initiative include guidance on COA data collection and a more open, collaborative environment.
A new study presents a proof-of-concept leptomeningeal neural organoid (LMNO) fusion model to study meninges-brain signaling. The co-culture system of neural organoids fused with fetal leptomeninges from mice demonstrates stability and interface characteristics.
A new study shows that comprehensive clinical assessments (CCAs) are equally effective to guiding treatment for women with overactive bladder or urinary incontinence, avoiding invasive urodynamics testing. CCA includes a medical questionnaire, physical examination, and tests such as urinalysis, revealing similar patient-reported outcom...
Researchers at the University of Zurich have developed a technology to test 25 antibodies simultaneously in a single mouse, greatly reducing the number of laboratory animals required. The method uses protein fragments as barcodes for analysis, allowing for high-quality preclinical data on multiple antibody candidates.
A new approach has been tested, bringing together child health services, specialist care, and the municipality, resulting in faster support for young children with autism. The average age at which children are diagnosed with autism has fallen from three years and eight months to two years and seven months.
Researchers have developed a new method to deliver antibiotics directly into the bladder tissue, eliminating over 90% of bacteria from the bladder. The nanogel-based drug delivery system shows promise in treating UTIs and could potentially lead to an eventual cure.
A Virginia Tech study reveals that machine learning models are inadequate in detecting critical patient conditions, missing 66% of injuries. The research emphasizes the need for more responsive models incorporating medical knowledge to improve healthcare outcomes.
Researchers found that women who received text message reminders were twice as likely to get their cervical cancer screenings within 150 days compared to those without reminders. The study suggests a promising low-cost approach to increasing cancer screenings in underserved populations.
Researchers have discovered a blood test that can identify patients with a sleep disorder who are most likely to develop Dementia with Lewy Bodies. The blood test analyzes two proteins in the blood associated with Alzheimer's disease and predicted dementia risk in almost 90% of patients, four years before symptoms appeared.
A study by Cambridge researchers found that a routine lung function test used to diagnose asthma is more reliable in the morning. The reliability of the test decreases throughout the day and differs significantly between winter and autumn, with individuals being 33% less likely to receive a positive result during autumn.
Researchers at Kyushu University have discovered a way to predict a potentially life-threatening side effect of cancer immunotherapy before it occurs. By analyzing cerebrospinal fluid, they identified specific proteins associated with an immune response that can affect the central nervous system after therapy.
Researchers found that p-tau proteins in blood are elevated in both Alzheimer's and ALS patients, making them less specific for Alzheimer's diagnosis. However, they also show promise as potential biomarkers for early detection of ALS or monitoring disease progression.
Children who frequently miss school due to abdominal complaints are more likely to have gut-brain axis disorders like IBS, which can be missed by medical tests. The study found that frequent absences were nearly five times more likely to be caused by functional GI disorders than specific illnesses.
Dr. Sarah Du, an associate professor at Florida Atlantic University's College of Engineering and Computer Science, has been selected as a Senior Member of the National Academy of Inventors for her significant contributions to advancing medical technology. Her research focuses on developing point-of-care diagnostic tools and monitoring ...
The AI-GS network achieves high accuracy with 93.52% sensitivity at 95% specificity, excelling in detecting early-stage glaucoma. The system is portable, requiring minimal computational power and delivering results in under a second.
Researchers at Osaka Metropolitan University have successfully generated feline embryonic stem cells, a major breakthrough for veterinary regenerative medicine. The high-quality stem cells can differentiate into various cell types and be transplanted to restore internal damage.
A new study led by the CIBEREHD group at Hospital Germans Trias demonstrates a significant improvement in monitoring and treatment of Crohn's disease patients. By analyzing calprotectin levels, patients can avoid unnecessary repeat colonoscopies.
Researchers have found that Continuous Glucose Monitors (CGMs) can overestimate blood sugar levels in healthy adults by up to 400%, potentially causing unnecessary worry and dietary restrictions. The study suggests that CGMs may not be a valid method for determining the glycaemic index of foods.
A cross-sectional study of social media posts about popular medical tests found most posts were misleading or failed to mention important harms, including overdiagnosis. The data suggest a pressing need for regulation of misleading medical information on social media platforms.
A new blood test may help identify and monitor Amyotrophic Lateral Sclerosis (ALS), according to a recent study published in Neurology. The test uses neurofilament light chain proteins to accurately diagnose ALS, with an accuracy rate of over 80%.
The project aims to improve the quality of life for patients with end-stage heart failure and their caregivers through a nurse-led intervention. The study will also track hospitalization rates, patient well-being, and gain a better understanding of end-of-life care.
A new study published in The Lancet Digital Health found that accelerated ageing in specific organs can predict diseases across the entire body. Organ ageing rates were linked to increased risks of various diseases, including cardiovascular disease, respiratory infections, and dementia.
A cohort study found that telemedicine adoption was associated with modestly lower use of 7 out of 20 examined low-value tests, while having no effect on other tests. The results suggest potential benefits of telemedicine and mitigate concerns about increased spending.
A large-scale study has found huge variation in GP practices on prostate cancer testing, with one in five patients diagnosed without symptoms. The study suggests a need for more consistent approach to testing people without symptoms to redress the imbalance.
Researchers developed reprogrammed vascular endothelial cells that provide strong support for islets, allowing them to survive and reverse diabetes long-term. The study showed that mice transplanted with islet cells plus R-VECs regained normal blood glucose control after 20 weeks.
Only about 1 in 5 older Americans have undergone cognitive screening in the past year, highlighting a persistent barrier to diagnosis and treatment. Researchers emphasize the importance of early conversations about cognitive health to prevent progression and improve outcomes.
A study analyzing 12 sunglasses models found that only one met international safety limits for UV radiation exposure. The lenses lose their ability to block UV radiation over time, increasing the risk of eye damage. To minimize this risk, scientists suggest adopting ICNIRP limits as standard practice.
Researchers at UCF aim to create mobile robotic assistants that offer easier control and a better robot-human interface. The project, supported by a $600,000 grant, will focus on testing and user feedback, with initial trials conducted with students and adults with upper body paralysis.
Amplified Sciences has received CLIA certification for its PanCystPro test, which helps risk stratify patients with pancreatic cystic lesions. The company plans to commercialize the test through an early access program and a clinical utility trial in 2025.
A new study published in Annals of Neurology found that lower concentrations of vitamin B12 in healthy, older adults led to signs of neurological and cognitive deficiency. These individuals showed slower processing speeds, brain lesions, and delayed responses to visual stimuli compared to those with higher B12 levels.
A new study at the University of Gothenburg found that a software robot can detect side effects faster than physicians during amiodarone treatment for cardiac arrhythmia. The robot also recommends appropriate intervals between lab tests, aligning with standard practices and reducing unnecessary testing.
A new blood test has shown promise in improving the accuracy of Alzheimer's Disease diagnosis, with results comparable to established CSF biomarkers. The study found that measuring plasma p-tau217 was over 90% accurate, potentially replacing invasive diagnostic methods for up to half of patients.
Researchers created a Spanish-language Android app called Impacto to support Hispanic smokers in quitting. The app's pilot test shows promising results, decreasing daily smoking rates and improving cessation rates among participants.
A blood test has been found to identify personalized dietary triggers for patients with irritable bowel syndrome, resulting in improved abdominal pain relief. The study showed that 59.6% of participants who removed trigger foods experienced significant reduction in abdominal pain compared to 42.2% in the control group.
Researchers discovered a link between neuroactive steroids in pregnant women's blood and the risk of developing postpartum depression. Measuring these molecules via a blood test could enable doctors to provide treatment sooner. The study may lead to a preventive treatment using existing prescription drugs.
Researchers at HSE Centre for Language and Brain create Russian-language adaptation of Rey Auditory Verbal Learning Test (RAVLT), suitable for testing adults of all ages. The adapted test has been incorporated into the RAVLT World tablet application, providing automated administration and scoring.
New cyanine-carborane salts show promise in eradicating metastatic breast cancer tumors with minimal side effects. The therapy targets specific proteins in cancer cells, allowing for precise killing of diseased cells while sparing healthy tissue.
A new study led by researchers at Mount Sinai Hospital found that children with high-threshold peanut allergy can be treated with a safe and effective approach, allowing them to tolerate larger doses of peanut butter. The treatment involves gradually increasing doses over 18 months, resulting in sustained unresponsiveness to peanuts fo...
Researchers developed a biomarker test that can detect small amounts of tau protein and its misfolded forms in cerebrospinal fluid, correlating with cognitive decline severity. The test identifies early stages of tau tangle formation up to a decade before brain scans, opening doors for early-stage disease diagnosis and intervention.
A new study at U-M Health shows that hospitals can focus the use of preoperative tests on high-risk patients, while safely reducing unnecessary testing in others. The result is less wasted money and resources, as well as less time wasted for patients and clinical staff.
The KeyScope is a low-cost, robust laparoscope priced at approximately $1,000, making it accessible in low- and middle-income countries. It offers high-resolution images, color accuracy, and low distortion, comparable to standard laparoscopes.
A new study led by UCL researchers has found that the GLP-1 drug exenatide has no positive impact on movement, symptoms, or brain imaging in people with Parkinson's disease. The trial involved 194 participants and ran for 96 weeks, with no benefits shown in any of these areas.
A new study by UC San Francisco found a marked increase in advanced prostate cancer rates across California since doctors stopped routine screening, with death rates plateauing in most regions. The study emphasizes the need for screening that can identify fatal tumors without raising false alarms.
ApoB100 protein structure revealed for the first time, allowing for more precise testing and treatment of high cholesterol and heart disease. The discovery may lead to new drugs targeting LDL particles, reducing side effects of statin drugs.
A large study on preterm birth found that a maternal biomarker test can reduce neonatal morbidities by 20% and NICU admissions by 20%. The test identified high-risk pregnant individuals, who received targeted treatment and showed significant improvements in neonatal outcomes.
A study from the University of Surrey reveals that delays in cancer diagnosis for pregnant women are often due to misattributed symptoms as normal pregnancy changes. Women experiencing more specific symptoms, such as breast lumps, are more likely to receive quicker diagnoses and referrals.
A new trial will test whether taking HMB can improve patients' physical function and quality of life. The BOOST study aims to recruit 124 patients with cirrhosis and measure its effects on liver disease, mental wellbeing, and physical function over 24 weeks.
Researchers tracked cfDNA levels before, during, and after colorectal cancer surgery, revealing significant increases associated with age, comorbidities, and surgical manipulation. The study suggests that cfDNA could serve as a non-invasive biomarker to monitor patient outcomes and evaluate surgical effectiveness.
A new study published in Nature Medicine shows a promising approach to preventing metastases in breast cancer patients. Researchers found that administering digoxin reduced circulating tumour cell clusters by an average of 2.2 cells, significantly decreasing the risk of metastasis.
A new microdosing approach using low doses of buprenorphine has been tested on patients with opioid use disorder, but most found it ineffective. The study, which included 126 participants, showed that only 34% were able to work up to a full dose of buprenorphine.
Researchers developed guidelines to compare lab experiments, molecular simulations, and AI for drug delivery testing. The new framework aims to improve the accuracy of permeability testing and accelerate the development of life-saving drugs.
UVA researchers analyzed 300 blood serum samples from babies who died from SIDS and identified specific biological indicators linked to their deaths. The study found 35 predictors of SIDS, including ornithine and a lipid metabolite critical for brain and lung health.
A study of 242 couples undergoing assisted reproductive treatment found that men experienced higher levels of work-family conflict, while women were more affected by stress. The researchers used online questionnaires to assess the couples' emotional well-being and job performance.
This study investigated the feasibility of electroacupuncture-assisted ribavirin dosing in patients with long COVID, using Voll's electropuncture diagnostics. The results demonstrated that EAV can identify meridians with decreased electrodermal activity at acupuncture points, followed by medicament testing to measure daily doses.
Researchers at Duke University developed an acoustofluidic integrated molecular diagnostics chip, AIMDx, that uses tiny vortexes to detect dangerous viruses. The vortexes trap cells, bacteria, and larger bioparticles, purifying samples for biomedical tests.
A large UK trial found that adding procalcitonin (PCT) to routine care did not reduce IV antibiotic use in hospitalized children. The study, part of the BATCH trial, enrolled nearly 2,000 children and tested PCT's effectiveness in guiding treatment decisions.
Researchers at UVA have developed computer models to target specific bacteria in specific parts of the body, reducing the chance of antibiotic resistance. This approach could lead to more effective treatments and reduce the need for broad-spectrum antibiotics.
The USPSTF concludes that screening for osteoporosis can help prevent fractures in older women. However, the effectiveness of screening for men is unclear due to insufficient evidence.
Preschool wheeze affects 30-40% of children under six, causing significant morbidity and healthcare costs. The UK has the second-highest prevalence in Europe, with inconsistent terminologies used by doctors contributing to diagnostic challenges.